Background
Computer-aided detection (CAD) may be a useful screening tool for tuberculosis (TB). However, there are limited data about its utility in active case finding (ACF) in a community-based setting, and particularly in an HIV-endemic setting where performance may be compromised.
Methods
We performed a systematic review and evaluated articles published between January 2012 and February 2023 that included CAD as a screening tool to detect pulmonary TB against a microbiological reference standard (sputum culture and/or nucleic acid amplification test [NAAT]). We collected and summarised data on study characteristics and diagnostic accuracy measures. Two reviewers independently extracted data and assessed methodological quality against QUADAS-2 criteria. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Diagnostic Test Accuracy Studies (PRISMA-DTA) were followed.
Results
Of 1,748 articles reviewed, five met with the eligibility criteria and were included in this review. Meta-analysis revealed pooled sensitivity of 0.87 (95% confidence interval [CI], 0.78-0.96) and specificity of 0.74 (95% CI, 0.55-0.93), just below the World Health Organization (WHO)-recommended target product profile (TPP) for a screening test (sensitivity ≥0.90 and specificity ≥0.70). We found a high risk of bias and applicability concerns across all studies. Sub-group analyses, including the impact of HIV and previous TB, were not possible due to the nature of reporting within the included studies.
Conclusion
This review provides evidence, specifically in the context of ACF, for CAD as a potentially useful and cost-effective screening tool for TB in a resource-poor HIV-endemic African setting. However, given methodological concerns, caution is required as regards to applicability and generalisability.